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Abstract
Antisense therapy for the treatment of bacterial infections is a very attractive alternative to overcome drug resistance
problems. However, the penetration of antisense oligonucleotides into bacterial cells is a major huddle that has delayed
research and application in this field. In the first part of this study, we defined efficient conditions to encapsulate plasmid
DNA and antisense oligonucleotides in a fluid negatively charged liposome. Subsequently, we evaluated the potential of
liposome-encapsulated antisense oligonucleotides to penetrate the bacterial outer membrane and to inhibit gene expression in
bacteria. It was found that 48.9 þ 12% and 43.5 þ 4% of the purified plasmid DNA and antisense oligonucleotides were
respectively encapsulated in the liposomes. Using fluorescence-activated cell sorting analysis, it was shown, after subtraction
of the fluorescence values due to the aggregation phenomenon measured at 4‡C, that about 57% of bacterial cells had
integrated the encapsulated antisense oligonucleotides whereas values for free antisenses were negligible. The uptake of the
encapsulated anti-lacZ antisense oligonucleotides resulted in a 42% reduction of L-galactosidase compared to 9% and 6% for
the encapsulated mismatch antisense oligonucleotides and the free antisense oligonucleotides respectively. This work shows
that it is possible to encapsulate relatively large quantities of negatively charged molecules in negative fluid liposomes and
suggests that fluid liposomes could be used to deliver nucleic acids in bacteria to inhibit essential bacterial genes. ß 2001
Elsevier Science B.V. All rights reserved.
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1. Introduction
The increase of bacterial resistance to conventional
antibiotics has become a major problem giving rise
to an urgent need for new approaches to treat bac-
terial infections. In cystic ¢brosis patients, pathogens
like Pseudomonas aeruginosa show high levels of re-
sistance and lead to progressive lung deterioration
and premature death [1^4]. To overcome antibiotic
resistance, £uid liposomes named Fluidosomes, a
negatively charged liposomal formulation without
cholesterol and made of a combination of dipalmi-
toylphosphatidylcholine (DPPC) and dimyristoyl-
phosphatidylglycerol (DMPG) phospholipids (at a
molar ratio from 5:1 to 18:1) were developed. These
liposomes with an overall low gel^liquid crystalline
0005-2736 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 1 ) 0 0 3 9 2 - 3
* Corresponding author. Fax: 514-343-6358.
E-mail address: jacqueline.lagace@umontreal.ca (J. Lagace¤).
BBAMEM 78156 28-9-01
Biochimica et Biophysica Acta 1515 (2001) 44^54
www.bba-direct.com
transition temperature (TC) 937‡C [5] were con-
ceived as a delivery vehicle to enhance drug penetra-
tion through bacterial membranes [6,7]. These £uid
liposome-encapsulated antibiotics succeed in eradi-
cating P. aeruginosa in an animal model of chronic
pulmonary infection [6]. Recently, the superior e⁄-
ciency of £uid liposome-encapsulated aminoglycoside
over rigid liposomes in an animal model of bacterial
infection was supported by an independent group [8].
The enhanced bactericidal activity of £uid liposomes
would result from a mechanism of fusion between
the liposomes and the bacterial membranes as dem-
onstrated by our group [9]. Previous studies analyz-
ing the innocuousness of £uid liposomes have dem-
onstrated that they do not induce an immune
response following repeated intraperitoneal and in-
tratracheal administrations to mice [10] and cannot
fuse with human lung epithelial cells [11].
Antisenses can regulate gene expression by binding
to a complementary mRNA strand by conventional
Watson^Crick hydrogen bonds, thereby providing
speci¢c targeting to the mRNA [12]. Because anti-
sense oligonucleotides are highly susceptible to intra-
cellular endonucleases, considerable e¡orts have been
made to develop chemical modi¢cations to improve
their stability. Phosphorothioate oligonucleotides are
the most commonly used and widely commercially
available chemically modi¢ed oligonucleotides, in
which the non-bridging oxygen atoms are replaced
by sulfur in the DNA backbone of the molecule.
This modi¢cation increases resistance to nuclease
degradation [13]. Selective inhibition of bacterial
genes to kill bacteria or to alter their resistance o¡ers
many advantages over conventional chemotherapies.
Antisense oligonucleotides can be speci¢cally de-
signed to target only bacterial sequences thus not
a¡ecting eukaryotic cells. Also, there are no known
mechanisms by which bacteria could expulse anti-
sense oligonucleotides outside their cytoplasm like
they do with common antibiotics using e¥ux pumps
[14^16]. Moreover, a recent study demonstrated that
the activities of drug e¥ux pumps do not a¡ect anti-
sense nucleic acid susceptibility [17].
In this study, we ¢rst tested di¡erent types of so-
lutions (NaCl, KCl, NaHCO3, MgCl2, CaCl2 and
phosphate-bu¡ered saline (PBS)) for the encapsula-
tion of plasmid DNA and antisense oligonucleotides
in negatively charged Fluidosomes. The second part
of this study consisted in the analysis of the uptake
of the encapsulated antisense oligonucleotides by Es-
cherichia coli CSH36 expressing a normal outer
membrane which was evaluated by £uorescence-acti-
vated cell sorting (FACS). The functional transfer of
DNA in an E. coli strain which constitutively ex-
presses the lacZ (L-galactosidase) gene due to a mu-
tation in the regulatory lacI gene, was assessed by the
reduction of L-galactosidase activity after the incuba-
tion of E. coli CSH36 with the encapsulated phos-
phorothioate anti-lacZ antisense oligonucleotide.
2. Materials and methods
2.1. Bacterial strain and antisenses
The pUC 18 plasmid (New England BioLabs, Bev-
erly, MA, USA) was used for the study of DNA
encapsulation. E. coli CSH36 (alternate name
E7074), a laboratory strain which constitutively ex-
presses the lacZ gene due to a mutation in the regu-
latory lacI gene, was used [18]. Bacteria were grown
in LB broth (Gibco BRL, Life Technologies, ON,
Canada). An anti-L-galactosidase antisense oligonu-
cleotide was designed to target the start codon region
of the E. coli L-galactosidase gene: 5P-GGT CAT
AGC TGT TTC-3P [19]. A mismatch antisense oligo-
nucleotide was also designed and used as a negative
control: 5P-TAC TGT GAT CTG TGC-3P. The anti-
sense oligonucleotides used in the present study had
a phosphorothioate backbone. This modi¢cation was
obtained by a substitution of a non-bridging oxygen
for a sulfur in the oligonucleotide backbone in order
to render the antisenses more stable and less subject
to degradation by endonucleases [19]. These phos-
phorothioate antisense oligonucleotides were ordered
from Alpha DNA (Montreal, QC, Canada). After
salt removal, the lyophilized oligonucleotides were
rehydrated with PBS 1X. FITC-labeled antisense oli-
gonucleotides used in uptake measurements were ob-
tained from Synthegen (Houston, TX, USA). Unless
otherwise indicated, encapsulated oligonucleotide
antisenses were added at a concentration of 10 WM.
2.2. Fluid liposomes
Fluid liposomes were prepared from synthetic
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phospholipids DPPC and DMPG (Avanti Polar Lip-
ids, Alabaster, AL, USA) at a molar ratio of 10:1.
Liposomes were prepared by a dehydration^rehydra-
tion vesicle (DRV) method as previously described
[6,9]. Brie£y, appropriate amounts of both phospho-
lipids were dissolved in chloroform in a round-bot-
tomed £ask and dried to a lipid ¢lm by rotoevapora-
tion (Bu«chi Rotavapor) at 65‡C under vacuum
(Bu«chi 168-Vacuum/Distillation Controller). The lip-
ids were then redissolved in PBS 1:20 and transferred
to screw neck diagnostic bottles with thin £ange ly-
ophilization stoppers designed for lyophilization and
hypodermic applications (Wheaton, NJ, USA). The
liposomes were then freeze-dried (Virtis Genesis 12
EL Console freeze dryer, Canberra Parkard, Toron-
to, ON, Canada) at 4‡C. At the end of the lyophili-
zation process, the bottles were mechanically closed
under vacuum. Finally, the stoppers were sealed with
aluminum caps and the bottles were kept at 370‡C
until use.
2.3. Encapsulation and quanti¢cation of the
enclosed DNA
The pUC 18 plasmid was puri¢ed using the Con-
cert Plasmid Maxiprep System (Life Technologies,
Gibco BRL, USA) and quanti¢ed by OD260 using
an UV-visible spectrophotometer (Milton Roy Spec-
tronic 1001 plus, USA). To encapsulate DNA, a vol-
ume of 0,5 ml of puri¢ed plasmid DNA (0.2 mg/ml
of encapsulation solution) or of antisense oligonu-
cleotides (7.4 mg/ml of PBS) was injected into the
diagnostic bottles containing the lyophilized phos-
pholipids (15 mg of phospholipids) which were kept
under vacuum during the procedure. The hydrated
phospholipids were vortexed until the powder was
completely dissolved in the DNA solution. The bot-
tles, still under vacuum, were incubated at 65‡C with
agitation (100 rpm) for 60 min. Vortexing was per-
formed every 10 min. After the incubation period,
the liposome^DNA solution was diluted in 9.5 ml
of encapsulation solutions. These solutions contained
either NaCl (50 mM and 150 mM), KCl (50 mM),
NaHCO3 (50 mM), CaCl2 (50 mM), or MgCl2 (50
mM) prepared in sterile distilled water and PBS
(NaCl 137 mM, KCl 2.7 mM, Na2HPO4 10 mM,
K2HPO4 1.8 mM). The diluted liposomes were cen-
trifuged at 6000Ug for 40 min in order to remove the
DNA present in the supernatant. Plasmid DNA (250
Wg) was resuspended in 1000 Wl of encapsulation so-
lution. Each encapsulation solution was tested at
least three times. The liposome diameters were het-
erogenous: about 63% of the size distribution mea-
surements of liposomes was shifted towards the di-
ameter range comprised between 316.2 and 562.3 nm
whereas about 46% consisted in large heterogeneous
vesicles as determined by an electronic particle size
analyzer (Coulters Electronics, Miami, FL, USA).
The antisense oligonucleotides encapsulated in
liposomes were quanti¢ed using Oligreen (Molecular
Probes, Eugene, OR, USA) as described by the man-
ufacturer, and a Perkin-Elmer LS-50B £uorescence
spectrophotometer (excitation at 490 nm, emission
at 520 nm). Before performing the cytometry studies,
a sample of the FITC-labeled antisense oligonucleo-
tides encapsulated in liposomes was submitted to
DNA extraction for quanti¢cation using a metha-
nol^chloroform (1:2) solution and a Perkin-Elmer
LS-50B £uorescence spectrophotometer (excitation
at 490 nm, emission at 520 nm).
2.4. Monitoring DNA localization
Two methods were used to con¢rm that DNA was
present inside and not outside of the liposomes. The
¢rst method consisted in placing DNA-encapsulated
liposomes and controls in an agarose gel (0.4%) con-
taining ethidium bromide (0.5 Wg/ml). The gel was
submitted to an electric current of 7 V/cm to obtain
free DNA migration. The second method to ascer-
tain that the measured DNA was contained inside
the liposomes consisted in treating the preparation
with DNase in order to eliminate the DNA present
outside of the liposomes. The DNase treatment for
15 mg of phospholipids rehydrated with 250 Wg of
DNA consisted in 250 DNase units, 5 mM MgCl2,
0.1 M sodium acetate and lasted for 3 h at room
temperature. The reaction was stopped with 20 mM
EDTA. After the DNase treatment, liposomes were
dissolved and separated from DNA as described be-
low. The DNA was quanti¢ed and compared to un-
treated liposome-encapsulated DNA. The control for
DNase activity consisted in adding an equivalent
amount of DNA to empty liposomes (externally),
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followed by treatment with DNase and quanti¢ca-
tion of the resulting DNA. All DNA quanti¢cations
in gels were determined visually.
2.5. UV absorbance measurements of DNA
To evaluate the e⁄ciency of DNA encapsulation
with the di¡erent encapsulation solutions, UV absor-
bance measurements were performed after liposomes
were dissolved in a methanol^chloroform (1:2) solu-
tion. The lipids were present in the organic phase
whereas DNA was found in the aqueous phase.
The aqueous phase containing plasmid DNA and
antisense oligonucleotides was diluted 1/100 in the
di¡erent encapsulation solutions and analyzed on
an Milton Roy Spectronic 1001 plus spectrophotom-
eter. Samples were placed in quartz cuvettes and
scanned at A260. Standard curves were drawn in the
di¡erent encapsulation solutions with concentrations
of DNA varying from 0.001 mg/ml to 0.5 mg/ml.
2.6. Delivery of the encapsulated antisense
oligonucleotides in E. coli
Bacteria were grown overnight in LB broth (Gibco
BRL, Life Technologies, ON, Canada). From this
culture, 300 Wl were added to 10 ml of fresh LB
broth. The culture was grown to mid-logarithmic
phase then diluted to an optical density (OD) of
0.05 at 600 nm. Six tubes containing the same vol-
ume of this bacterial culture were prepared and dif-
ferent concentrations of free FITC-labeled antisense
oligonucleotides, encapsulated FITC-labeled anti-
sense oligonucleotides and PBS-containing liposomes
were added. Bacteria were incubated for 4 h at 37‡C
with vigorous shaking. Samples from each tube were
placed on the surface of a 24% sucrose (Sigma, ON,
Canada) cushion and centrifuged at 4‡C for 20 min
(6000 rpm) in an Eppendorf Centrifuge 5402. Bacte-
ria were washed once with LB broth, then placed on
another sucrose cushion and centrifuged. The super-
natant was discarded and the ¢nal cell pellet was
¢xed with 2% paraformaldehyde (Sigma) diluted in
PBS. The solutions were kept at 4‡C overnight. Bac-
teria were analyzed by means of a FACS Calibur
£ow cytometer (Becton Dickinson). Forward angle
(FSC) and 90‡ light (side) scattering (SSC) measure-
ments as well as green (FL1) £uorescence were col-
lected, and 10 000 events were counted for each sam-
ple. The purity of the bacterial population sorted
after electronic gating was closed to 100%.
2.7. Determination of L-galactosidase activity
Bacteria were prepared as described above. Free
antisense oligonucleotides, encapsulated antisense
oligonucleotides, encapsulated mismatch antisense
oligonucleotides, free mismatch oligonucleotides
and encapsulated PBS were added to bacteria and
incubated for 4 h at 37‡C with agitation. In this
assay, a single data point of 4 h was selected based
on the results obtained following the time course of
the FACS analysis. Samples from each tube were
placed on the surface of a 24% sucrose cushion and
centrifuged for 20 min at 6000 rpm, 4‡C. Superna-
tants were discarded and bacteria were resuspended
in Z bu¡er (8.52 g Na2HPO4, 5.5 g NaH2PO4WH2O,
0.75 g KCl, 0.246 g MgSO4W7H2O, 2.7 ml L-mer-
captoethanol per liter; pH 7). L-Galactosidase con-
centration was measured using the substrate o-nitro-
phenyl-L-galactoside (Sigma) as previously described
[18] with minor modi¢cations: after the incubation
period with the substrate, the bacteria were treated
with 20 Wl of chloroform (EM Science, Gibbstown,
NJ, USA) and 20 Wl of 0.1% SDS (Bio-Rad,
Hercules, CA, USA). The solution was vortexed for
10 s and placed at 30‡C for 5 min. The absorbance
was measured at 420 nm using a spectrophotometer
(Milton Roy Spectronic 1001 Plus).
3. Results
3.1. DNA encapsulation with the di¡erent
encapsulation solutions
The two encapsulation solutions containing CaCl2
(50 mM, pH 7.0) or MgCl2 (50 mM, pH 7.0) caused
the DNA and liposomes to precipitate thus allowing
visualization by ethidium bromide staining in the
agarose gel where the DNA was visible in the wells
at the end of the migration period (Fig. 1b, lanes 1,
4, 7, 10). Also, a precipitate was visible when the
solution was observed in the tube. The encapsulation
solutions composed of salts containing monova-
lent cations, either NaCl (50 mM, and 150 mM,
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pH 7.0), KCl (50 mM, pH 7.0) or NaHCO3 (50 mM,
pH 7.0) and PBS were e⁄cient in promoting the
encapsulation of DNA in liposomes. At ¢rst, when
these liposomes were placed in agarose gels, encap-
sulated DNA could not migrate, nor could it be de-
tected in the wells (Fig. 1b, lanes 2, 3, 5, 6, 8, 9).
However, following the lysis of these liposomes, mi-
grating DNA could be observed (Fig. 1a, lanes 10,
11, 13, 16, 17, 19). The quantities of DNA detected
in the gels after DNase treatment (lanes 10, 11, 13)
were approximately the same and corresponded to
about 50% of the DNA signal given by the initial
DNA preparation dissolved in the encapsulation so-
lution before encapsulation (Fig. 1a, lanes 2, 3, 5).
Negligible di¡erences in DNA quantities were ob-
served between untreated (lanes 16, 17, 19) and
DNase-treated liposome-encapsulated DNA (lanes
10, 11, 13).
The UV absorbance measurements of extracted
DNA from eight independent preparations of lipo-
some-encapsulated plasmid DNA and three inde-
pendent preparations of encapsulated antisense oli-
gonucleotides in PBS gave a mean encapsulation of
48.87 þ 11.65% and 43.53 þ 4.32% respectively.
3.2. Delivery of the encapsulated antisense
oligonucleotides in bacteria
FACS analysis was performed at 37‡C to deter-
mine if encapsulated antisense oligonucleotides could
e⁄ciently be delivered to bacteria. To assure that
liposomes do not sediment at all during centrifuga-
tion through the sucrose cushion, a preliminary test
was performed that consisted in adding only lipo-
somes on the surface of the sucrose cushion. The
cytometry analysis of the lower part (no pellet was
Fig. 1. (a, upper gel) Evaluation of DNA quantity before and after treatment of liposomes with DNase. Initial preparations of DNA
in the di¡erent encapsulation solutions (no liposomes) (lanes 1^5), DNA after dissolving liposomes with methanol^chloroform (1:2)
solution (lanes 15^19) and after DNase treatment of liposomes (external DNA) followed by dissolving liposomes (lanes 9^13). Encap-
sulation solutions: CaCl2 (lanes 1, 9, 15), NaCl (lanes 2, 10, 16), KCl (lanes 3, 11, 17), MgCl2 (lanes 4, 12, 18), and NaHCO3 (lanes
5, 13, 19). NaCl solution controls without DNA (lanes 6, 14, 20); DNA controls in CaCl2 and in NaCl without DNase treatment
(lanes 7 and 8 respectively) and after DNase treatment (lanes 21 and 22 respectively). Electrophoresis was performed in a 0.4% aga-
rose gel. (b, lower gel) Demonstration of the absence of migration with whole liposomes without DNase treatment (lanes 1^5); after
DNase treatment (7^11). Control NaCl solution without DNA (lanes 6, 12). Encapsulation solutions: CaCl2 (lanes 1, 7), NaCl (lanes
2, 8), KCl (lanes 3, 9), MgCl2 (lanes 4, 10), and NaHCO3 (lanes 5, 11).
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visible) of the gradient showed a total absence of
liposomes in this fraction. Other controls indicated
that bacteria did not emit intrinsic £uorescence (Fig.
2A) and no £uorescence was detected with £uid lipo-
somes containing PBS used as negative control (data
not shown). Bacteria treated with free antisense oli-
gonucleotides showed very low levels of £uorescence
(9.78%) (Fig. 2B). After a 4 h incubation period of
the bacteria with encapsulated FITC-antisense oligo-
nucleotides, 71.25% of bacteria showed FITC-£uo-
rescence (Fig. 2C). To evaluate the extent of the ag-
gregation phenomenon of liposomes and antisenses
on the outer bacterial membrane versus the penetra-
tion of antisense in bacteria by liposome fusion, a
kinetic study was performed at 4‡C and 37‡C. The
results indicate that at time zero, £uorescence values
were the same at 4‡C and 37‡C; after 4 h of incuba-
tion at 37‡C, the bacterial £uorescence due to the
liposome-encapsulated oligonucleotide transfer
strongly increased with time (Fig. 3). After subtrac-
tion of values obtained at time zero, the £uorescence
that may be caused by agglutination (observed at
4‡C) counted for 17% and 20% after 120 and 240
min respectively for the encapsulated antisenses com-
pared to 43% and 100% after 120 and 240 min re-
spectively for the free antisenses (Fig. 3). This means
that at the end of the experiment, aggregation only
was observed between the free antisenses and the
bacterial cells. On the other hand, 80% of the £uo-
rescence observed with the encapsulated antisenses
corresponded to a true antisense internalization
which corresponded to 57%.
3.3. Determination of the L-galactosidase activity
The mismatch antisense oligonucleotide used as
negative control contained the same amount of T,
A, G and C deoxyribonucleotides as the anti-lacZ
antisense oligonucleotide but in a di¡erent order.
The addition of 25 WM of the encapsulated anti-
lacZ antisense oligonucleotide to E. coli, with an in-
cubation period of 4 h at 37‡C, caused a signi¢cant
reduction of L-galactosidase of 42% compared to 9%
and 6% for the encapsulated mismatch antisense oli-
gonucleotide and the free antisense oligonucleotide
respectively (Fig. 4). This result demonstrates that
the encapsulated antisenses not only enter the bacte-
rial cells, but interact with the target mRNA. In the
second L-galactosidase assay, a dose-dependent ac-
tivity using 5, 10, and 25 WM encapsulated antisense
oligonucleotides causes the inhibition of the L-galac-
tosidase whereas a plateau was reached with 50 WM.
Fig. 2. Flow cytometry histograms of E. coli CSH36 after a 4 h
incubation period at 37‡C. (A) Control bacteria; (B) bacteria
with free FITC-labeled antisense oligonucleotides; (C) bacteria
with encapsulated FITC-labeled antisense oligonucleotides. The
x-axis represents mean £uorescence intensity and the y-axis bac-
terial counts.
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Gradual inhibitions of L-galactosidase activity of 4%,
26% and 42% were observed with the encapsulated
antisense at 5, 10 and 25 WM respectively compared
to w2^6% with free antisense and 0^9% with the
encapsulated mismatch antisense (Fig. 5). The inhi-
bition of the L-galactosidase gene expression was
dose-dependent (Fig. 5) and was inhibited in a sig-
ni¢cant manner only with the encapsulated anti-lacZ
antisense oligonucleotide (Fig. 5). Free mismatch
antisense oligonucleotide showed no gene inhibition
(data not shown). Finally, our results show that the
phosphorothioate antisense oligonucleotides were
not degraded during the 4 h period at 37‡C since
their activity was maintained over that period of
time.
4. Discussion
Multiple modes of DNA delivery have been devel-
oped for gene therapy [20]. Among the problems
associated with DNA transfer in cells are the stability
of the carrier DNA complex, toxicity and the e⁄-
cient delivery to and expression of the desired
DNA in the cytoplasm. The use of viral particles, a
very e⁄cient method for gene delivery, involves po-
tential risks of infection, immune reaction and may
both slow the cell cycle and induce apoptosis [21,22].
Although cationic liposome^DNA complexes present
advantages over viral vectors, they have also major
limitations due to aggregation behavior [23^25], sig-
ni¢cant toxicity [26^29] and low transgene expression
Fig. 3. Kinetics of antisense uptake in bacteria measured by FACS analysis as described in the text. E, control bacteria; l, free anti-
sense oligonucleotides; F, encapsulated antisense oligonucleotides. (A) Experiment conducted at 37‡C; (B) experiment conducted at
4‡C.
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[30,31]. Moreover, the problem of toxicity is a com-
plex one since it would be independent of the cation-
ic lipid:DNA ratio, the cationic lipid species and the
level of transgene expression attained [27]. It has
been suggested that the mechanism of toxicity of cat-
ionic lipids would depend on the alterations of the
net charge of cell membranes and adverse e¡ects on
the activity of ion channels, membrane receptors,
and enzymes [32]. Another problem met with cation-
ic liposome-mediated transfection is the low release
Fig. 4. E¡ect of the encapsulated anti-lacZ antisense oligonucleotides on the L-galactosidase expression in E. coli CSH38 after a 4 h
incubation period at 37‡C with 25 WM of antisense oligonucleotides.
Fig. 5. Dose-dependent (WM) inhibition of the L-galactosidase gene in E. coli CSH38 after a 4 h incubation period at 37‡C. E, free
antisense oligonucleotides; l, encapsulated mismatch antisense oligonucleotides; F, encapsulated anti-lacZ antisense oligonucleotides
(data for free mismatch antisense oligonucleotides are not shown because all values were negative).
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of plasmid DNA from the liposome^DNA complex
for e⁄cient gene expression [33,34].
In the present work, entrapment of DNA in
anionic DPPC/DMPG liposomes prepared with the
DRV method using encapsulation solutions made of
monovalent salts was signi¢cant both with plasmid
DNA (48.3%) and antisense oligonucleotides
(43.5%). Similar plasmid DNA entrapment values
were reported with anionic PC:CHOL:PG liposomes
[35]. It also appears that in solutions made with
monovalent salts, the DNA quanti¢ed was practi-
cally only within the liposome considering that: (i)
following its encapsulation, the DNA was protected
from DNase degradation as demonstrated by the fact
that approximately the same amount of DNA was
detected in untreated and treated liposome-encapsu-
lated DNA; (ii) free DNA could not be observed in
agarose gel following the DNase treatment; (iii) en-
capsulated DNA could not be observed with ethid-
ium bromide in agarose gel; (iv) DNA could be ob-
served in agarose gel after lysis of the DNA-
encapsulated liposomes. It seems that, in contrast
to DNA^liposome complexes where DNA is exter-
nal, internalization of DNA would be favored in the
multilamellar liposomes generated by the DRV pro-
cess [35]. Moreover, in our hands, the addition of
DNA preparation to the lyophilized liposomes under
vacuum conditions during the whole process of rehy-
dration contributes to the e⁄ciency of the encapsu-
lation procedure.
Liposomes are versatile drug carriers which can be
associated with both hydrophilic and hydrophobic
molecules. The ¢nding that a plasmid DNA^cationic
liposome complex microinjected directly into the nu-
cleus showed low transfection e⁄ciency supports the
hypothesis that the release of plasmid DNA from the
complex is necessary for e⁄cient gene expression in
liposome-mediated transfection [34]. Xu and co-
workers demonstrated that the anionic liposomes
with a composition that mimics the cytoplasmic-fac-
ing monolayer of the plasma membrane rapidly re-
leased plasmid DNA from the complex [36]. In the
absence of calcium ions, DNA molecules have no
e¡ect on negatively charged liposomes because elec-
trostatic repulsion prevents its interaction with
anionic multilamellar vesicles [37]. Consequently,
the use of anionic liposomes could help the release
into cytoplasm of plasmid DNA from the liposome^
DNA complex, a required step to the subsequent
gene expression e⁄ciency.
FACS analysis clearly shows that bacterial uptake
of encapsulated antisense oligonucleotides is higher
than the uptake of free antisense oligonucleotides.
The di¡erence in number of £uorescent bacteria be-
tween the two preparations is very signi¢cant since it
reached 71.25% with the encapsulated antisense oli-
gonucleotides compared to 9.78% for the free ones
(Fig. 2). By running the same experiment at 4‡C and
37‡C (Fig. 3), the values of £uorescence correspond-
ing to aggregation (values obtained at 4‡C) could be
excluded. The results indicate that after an incuba-
tion period of 4 h at 37‡C with the encapsulated
antisense, the true value of the £uorescent antisense
in the bacterial cells was 57% instead of 71%. More-
over, the same operation performed on the £uores-
cence values due to free antisense indicates that the
aggregation phenomenon represents the whole value
of the observed £uorescence at the end of the experi-
ment.
To demonstrate the activity of the anti-lacZ anti-
sense oligonucleotides after their internalization in
the bacterial cells, the inhibition of L-galactosidase
production by E. coli CSH36, a bacterial strain
that constitutively produces L-galactosidase, was
measured. This strain was selected to avoid the addi-
tion of isopropyl L-D-thiogalactoside (IPTG) to the
preparation since the latter could have been trapped
in the £uid liposomes. In this case, IPTG would have
been inaccessible to the surrounding bacteria and
could have interfered with the normal induction of
the targeted gene. To avoid the degradation of the
antisense oligonucleotides by endonucleases, the anti-
senses used in the present study had a phosphoro-
thioate backbone obtained by a substitution of a
non-bridging oxygen by a sulfur in the nucleotide
backbone. The stability of the antisenses used is
well demonstrated by the results obtained after an
incubation period of 4 h (Fig. 3). A control using a
non-modi¢ed antisense showed no gene inhibition
(data not shown). The L-galactosidase inhibition ob-
tained with the encapsulated anti-lacZ antisense oli-
gonucleotides was concentration-dependent and
reached a maximum level of 45% (Figs. 4 and 5).
This limit is close to the percentage of bacterial cells
(57%) which apparently show a true internalization
of the antisense oligonucleotides from the liposomes.
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The limit can also be related to the non-toxic e¡ect
of the antisense for the bacteria. Thus, after the ad-
dition of the liposome-encapsulated anti-lacZ anti-
sense oligonucleotides that combined with the bacte-
ria, the sustained growing of new bacterial cells
would continue to produce L-galactosidase during
the 4 h incubation period. At concentrations of 25
and 50 WM, the encapsulated mismatch antisense oli-
gonucleotides showed an inhibition of about 8%.
This low level of inhibition could be attributed to a
non-speci¢c steric hindrance after the penetration of
the mismatch antisense into the bacterial cells. Some
may argue that the diameter range of the majority of
the liposomes that shifts towards 316^562 nm seems
too large to allow fusion with bacteria of 1^5 Wm
dimension. The fusion mechanism of the £uid lipo-
somes with bacteria does not necessarily implicate
the penetration of the whole liposome into the bac-
teria. It is possible that a partial fusion between bac-
terial and liposomal membranes occurs, allowing the
penetration into the bacterial cytoplasm of liposome-
containing molecules. The well known conjugation
process that exports e¡ector molecules into other
cells demonstrates that such a transfer is possible.
This hypothesis is not inconsistent with our previous
work on the mechanism of fusion [9] and with the
present results.
In conclusion, we showed that £uid anionic DRV
liposomes can encapsulate, under vacuum condition,
signi¢cant amounts of plasmid and oligonucleotide
DNA using monovalent salt solutions. It is also dem-
onstrated that DNA is entrapped within the multi-
lamellar vesicles rather than being adsorbed to their
surface. Because the toxicity problem of cationic
liposomes may limit their clinical use, di¡erent types
of anionic liposomes could be used to introduce
genes both in bacterial and mammalian cells and
enhance their expression. This study also suggests
that anionic £uid liposomes directed at an essential
gene start codon could be e⁄ciently delivered inside
bacteria and inhibit the gene’s expression to eventu-
ally eliminate bacterial strains resistant to conven-
tional antibiotics.
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